phenofAST

phenofAST is at the forefront of developing innovative medical device technologies to combat antimicrobial resistance (AMR). With a focus on fast, affordable, and accurate diagnostic methods for bacterial antibiotic sensitivity, phenofAST is dedicated to transforming patient care and reducing healthcare costs.

phenofAST's cutting-edge technology significantly shortens test times, providing antimicrobial susceptibility testing (AST) results in just 3-4 hours from culture. This rapid analysis enables physicians to prescribe effective treatments promptly, preventing inappropriate treatment complications and shortening hospital stays. By using lab automation and a disposable cassette format containing multiple antibiotic types and concentrations, phenofAST ensures comprehensive and affordable antimicrobial solutions.

Based on label-free laser diffraction, phenofAST's technology directly detects bacterial cells without relying on expensive molecular transducers or biochemical reactions. This approach not only accelerates diagnostic outcomes but also makes the testing process more cost-effective. phenofAST is committed to addressing the global challenge of AMR by delivering accessible, affordable, and rapid diagnostic solutions. We invite the management team to create a customized and exclusive company showcase and product listing on our platform.